Description
SUS 250 – Testosterone Sustanon 250mg/ml
SUS 250 is a multi-ester testosterone blend delivering 250mg/ml of four different testosterone esters: propionate, phenylpropionate, isocaproate, and decanoate. This combination is designed to provide both immediate and sustained release, offering a stable hormonal profile over time with fewer injections.
The strategic ester blend allows SUS 250 to deliver rapid results in muscle strength and performance while maintaining elevated testosterone levels for extended periods. It supports muscle growth, boosts recovery, enhances nitrogen retention, and improves red blood cell production, all critical for high-performance training phases.
Application:
Ideal for intermediate to advanced users, SUS 250 is effective as a stand-alone product or in combination with other anabolic agents such as Nandrolone Decanoate or Boldenone. It is commonly used in both bulking and recomp protocols due to its versatile pharmacodynamics.
Important Note:
SUS 250, like all testosterone-based compounds, suppresses natural testosterone production. Post-cycle therapy (PCT) is required.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.